Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI): What Does The Future Look Like?

Brainstorm Cell Therapeutics Inc's (NASDAQ:BCLI) latest earnings announcement in December 2017 showed that losses became smaller relative to the prrior year's level as a result of recent tailwinds Below, I've laid out key growth figures on how market analysts perceive Brainstorm Cell Therapeutics's earnings growth trajectory over the next couple of years and whether the future looks brighter. I will be looking at earnings excluding extraordinary items to exclude one-off activities to get a better understanding of the underlying drivers of earnings. View our latest analysis for Brainstorm Cell Therapeutics

Analysts' outlook for the coming year seems pessimistic, with earnings becoming even more negative, generating -US$21.30M in 2019. Additionally, earnings are predicted to fall off in the following year, before bouncing back up again to -US$19.81M in 2021.

While it’s helpful to understand the rate of growth each year relative to today’s figure, it may be more beneficial gauging the rate at which the company is moving on average every year. The pro of this technique is that it removes the impact of near term flucuations and accounts for the overarching direction of Brainstorm Cell Therapeutics's earnings trajectory over time, be more volatile. To compute this rate, I've inserted a line of best fit through analyst consensus of forecasted earnings. The slope of this line is the rate of earnings growth, which in this case is 57.69%. This means, we can anticipate Brainstorm Cell Therapeutics will grow its earnings by 57.69% every year for the next couple of years.

Next Steps:

For Brainstorm Cell Therapeutics, there are three essential aspects you should further research:

1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
2. Valuation: What is BCLI worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether BCLI is currently mispriced by the market.
3. Other High-Growth Alternatives: Are there other high-growth stocks you could be holding instead of BCLI? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.